Shandong Bailong Chuangyuan Bio-Tech 대차 대조표 상태
재무 상태 기준 확인 6/6
Shandong Bailong Chuangyuan Bio-Tech has a total shareholder equity of CN¥1.6B and total debt of CN¥71.3M, which brings its debt-to-equity ratio to 4.4%. Its total assets and total liabilities are CN¥1.9B and CN¥306.3M respectively. Shandong Bailong Chuangyuan Bio-Tech's EBIT is CN¥239.3M making its interest coverage ratio -23.6. It has cash and short-term investments of CN¥408.7M.
주요 정보
4.4%
부채 비율
CN¥71.32m
부채
| 이자 보상 비율 | -23.6x |
| 현금 | CN¥408.66m |
| 주식 | CN¥1.62b |
| 총 부채 | CN¥306.30m |
| 총 자산 | CN¥1.93b |
최근 재무 상태 업데이트
업데이트 없음
Recent updates
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.'s (SHSE:605016) Intrinsic Value Is Potentially 78% Above Its Share Price
Oct 14
Many Still Looking Away From Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016)
Sep 29Here's Why Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Has Caught The Eye Of Investors
Aug 23Returns On Capital At Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Have Hit The Brakes
Jun 26Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHSE:605016) Analysts Are More Bearish Than They Used To Be
May 06Concerns Surrounding Shandong Bailong Chuangyuan Bio-Tech's (SHSE:605016) Performance
May 03If EPS Growth Is Important To You, Shandong Bailong Chuangyuan Bio-Tech (SHSE:605016) Presents An Opportunity
Mar 27재무 상태 분석
단기부채: 605016's short term assets (CN¥856.6M) exceed its short term liabilities (CN¥301.4M).
장기 부채: 605016's short term assets (CN¥856.6M) exceed its long term liabilities (CN¥4.9M).
부채 대 자본 내역 및 분석
부채 수준: 605016 has more cash than its total debt.
부채 감소: 605016's debt to equity ratio has reduced from 9.5% to 4.4% over the past 5 years.
부채 범위: 605016's debt is well covered by operating cash flow (304.8%).
이자 보장: 605016 earns more interest than it pays, so coverage of interest payments is not a concern.